Domingo, E., Camps, C., Kaisaki, P., Parsons, M., Mouradov, D., Pentony, M., . . . Tomlinson, I. (2018). Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent. Elsevier.
Lua i Stíl Chicago (17ú heag.)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
Lua MLA (9ú heag.)Domingo, E., et al. Mutation Burden and Other Molecular Markers of Prognosis in the QUASAR2 Clinical Trial of Colorectal Cancer Treated with Curative Intent. Elsevier, 2018.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.